Literature DB >> 8438342

Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.

D K Cooper1, A H Good, Y Ye, E Koren, R Oriol, R M Ippolito, A J Malcolm, F A Neethling, E Romano, N Zuhdi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8438342

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Establishment of a human DAF/HRF20 double transgenic mouse line is not sufficient to suppress hyperacute rejection.

Authors:  C Koike; K Isobe; I Nakashima; H Okada; S Hayashi; I Yokoyama; H Takagi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.

Authors:  M S Sandrin; H A Vaughan; P L Dabkowski; I F McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.